text
"['\n2. 주요 제품 및 서비스\n가. 매출에 관한 사항(1) 주요 제품, 서비스 등의 현황\r\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 (단위 : 천원,%)\n사업부문\n주요품목\n금액\n비중\n의약품\n\xa0리피다운캡슐60mg 90C(PTP)\n510,376\n3.4\n\xa0뷰스타캡슐 500C\n217,910\n1.4\n\xa0레바미드정100MG 300T\n213,649\n1.4\n\xa0기타\n12,001,403\n79.8\n소계\n12,943,338\n86.0\n메디컬\n\xa0ATTUNE CR FEMORAL CEM\xa0\n52,829\n0.4\n\xa0Triathlon Femoral Component\xa0\n51,178\n0.3\n\xa0Triathlon X3 Tibial Insert\xa0\n23,081\n0.2\n\xa0기타\n1,972,467\n13.1\n소계\n2,099,555\n14.0\n합계\n15,042,893\n100.0\n나. 주요 제품 등의 가격 변동추이\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0(단위 : 원)\n사업부문\n품목\n당분기\n전기\n의약품\n\xa0리피다운캡슐60mg 90C(PTP)\n32,922\n32,922\n\xa0뷰스타캡슐 500C\n63,480\n63,480\n\xa0레바미드정100MG 300T\n30,900\n30,900\n메디컬\n\xa0ATTUNE CR FEMORAL CEM\xa0\n544,800\n544,800\n\xa0Triathlon Femoral Component\xa0\n533,647\n526,680\n\xa0Triathlon X3 Tibial Insert\xa0\n240,643\n237,490\n']"
